Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis

1. Advancing melanoma treatment with nanoparticles: from chemotherapy to combination therapies

   Chou‐Yi Hsu, Sulieman Ibraheem Shelash Al-Hawary, Asokan Vasudevan +7

   МақолаCurcumin's Biomedical ApplicationsNanomedicine20250 иқтибос

   ABIABI:AkademIndex/openalex/2025.article.002580

2. Disrupting immune silence: Noncoding RNAs targeting the programmed cell death protein 1/programmed cell death ligand 1 axis in tumor immunity

   Chou-Yi Hsu, Ahmed Hjazi, Muath Suliman +7

   МақолаCancer Immunotherapy and BiomarkersJournal of Pharmacology and Experimental Therapeutics20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.005985